1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Squamous Cell Carcinoma of the Head and Neck Treatment Market Size Growth Rate by Type: 2017 VS 2021 VS 2028 1.2.2 Salivary Gland 1.2.3 Oral & Oropharyngeal 1.2.4 Nasal Cavity & Paranasal Sinus 1.2.5 Nasopharyngeal 1.2.6 Laryngeal & Hypo Pharyngeal 1.3 Market by Application 1.3.1 Global Squamous Cell Carcinoma of the Head and Neck Treatment Market Share by Application: 2017 VS 2021 VS 2028 1.3.2 Hospitals 1.3.3 Specialty Clinics 1.3.4 Ambulatory Surgical Centers 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Squamous Cell Carcinoma of the Head and Neck Treatment Market Perspective (2017-2028) 2.2 Squamous Cell Carcinoma of the Head and Neck Treatment Growth Trends by Region 2.2.1 Squamous Cell Carcinoma of the Head and Neck Treatment Market Size by Region: 2017 VS 2021 VS 2028 2.2.2 Squamous Cell Carcinoma of the Head and Neck Treatment Historic Market Size by Region (2017-2022) 2.2.3 Squamous Cell Carcinoma of the Head and Neck Treatment Forecasted Market Size by Region (2023-2028) 2.3 Squamous Cell Carcinoma of the Head and Neck Treatment Market Dynamics 2.3.1 Squamous Cell Carcinoma of the Head and Neck Treatment Industry Trends 2.3.2 Squamous Cell Carcinoma of the Head and Neck Treatment Market Drivers 2.3.3 Squamous Cell Carcinoma of the Head and Neck Treatment Market Challenges 2.3.4 Squamous Cell Carcinoma of the Head and Neck Treatment Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Squamous Cell Carcinoma of the Head and Neck Treatment Players by Revenue 3.1.1 Global Top Squamous Cell Carcinoma of the Head and Neck Treatment Players by Revenue (2017-2022) 3.1.2 Global Squamous Cell Carcinoma of the Head and Neck Treatment Revenue Market Share by Players (2017-2022) 3.2 Global Squamous Cell Carcinoma of the Head and Neck Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.3 Players Covered: Ranking by Squamous Cell Carcinoma of the Head and Neck Treatment Revenue 3.4 Global Squamous Cell Carcinoma of the Head and Neck Treatment Market Concentration Ratio 3.4.1 Global Squamous Cell Carcinoma of the Head and Neck Treatment Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Squamous Cell Carcinoma of the Head and Neck Treatment Revenue in 2021 3.5 Squamous Cell Carcinoma of the Head and Neck Treatment Key Players Head office and Area Served 3.6 Key Players Squamous Cell Carcinoma of the Head and Neck Treatment Product Solution and Service 3.7 Date of Enter into Squamous Cell Carcinoma of the Head and Neck Treatment Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Squamous Cell Carcinoma of the Head and Neck Treatment Breakdown Data by Type 4.1 Global Squamous Cell Carcinoma of the Head and Neck Treatment Historic Market Size by Type (2017-2022) 4.2 Global Squamous Cell Carcinoma of the Head and Neck Treatment Forecasted Market Size by Type (2023-2028) 5 Squamous Cell Carcinoma of the Head and Neck Treatment Breakdown Data by Application 5.1 Global Squamous Cell Carcinoma of the Head and Neck Treatment Historic Market Size by Application (2017-2022) 5.2 Global Squamous Cell Carcinoma of the Head and Neck Treatment Forecasted Market Size by Application (2023-2028) 6 North America 6.1 North America Squamous Cell Carcinoma of the Head and Neck Treatment Market Size (2017-2028) 6.2 North America Squamous Cell Carcinoma of the Head and Neck Treatment Market Size by Country (2017-2022) 6.3 North America Squamous Cell Carcinoma of the Head and Neck Treatment Market Size by Country (2023-2028) 6.4 United States 6.5 Canada 7 Europe 7.1 Europe Squamous Cell Carcinoma of the Head and Neck Treatment Market Size (2017-2028) 7.2 Europe Squamous Cell Carcinoma of the Head and Neck Treatment Market Size by Country (2017-2022) 7.3 Europe Squamous Cell Carcinoma of the Head and Neck Treatment Market Size by Country (2023-2028) 7.4 Germany 7.5 France 7.6 U.K. 7.7 Italy 7.8 Russia 7.9 Nordic Countries 8 Asia-Pacific 8.1 Asia-Pacific Squamous Cell Carcinoma of the Head and Neck Treatment Market Size (2017-2028) 8.2 Asia-Pacific Squamous Cell Carcinoma of the Head and Neck Treatment Market Size by Country (2017-2022) 8.3 Asia-Pacific Squamous Cell Carcinoma of the Head and Neck Treatment Market Size by Country (2023-2028) 8.4 China 8.5 Japan 8.6 South Korea 8.7 Southeast Asia 8.8 India 8.9 Australia 9 Latin America 9.1 Latin America Squamous Cell Carcinoma of the Head and Neck Treatment Market Size (2017-2028) 9.2 Latin America Squamous Cell Carcinoma of the Head and Neck Treatment Market Size by Country (2017-2022) 9.3 Latin America Squamous Cell Carcinoma of the Head and Neck Treatment Market Size by Country (2023-2028) 9.4 Mexico 9.5 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Squamous Cell Carcinoma of the Head and Neck Treatment Market Size (2017-2028) 10.2 Middle East & Africa Squamous Cell Carcinoma of the Head and Neck Treatment Market Size by Country (2017-2022) 10.3 Middle East & Africa Squamous Cell Carcinoma of the Head and Neck Treatment Market Size by Country (2023-2028) 10.4 Turkey 10.5 Saudi Arabia 10.6 UAE 11 Key Players Profiles 11.1 Sanofi 11.1.1 Sanofi Company Detail 11.1.2 Sanofi Business Overview 11.1.3 Sanofi Squamous Cell Carcinoma of the Head and Neck Treatment Introduction 11.1.4 Sanofi Revenue in Squamous Cell Carcinoma of the Head and Neck Treatment Business (2017-2022) 11.1.5 Sanofi Recent Development 11.2 Pfizer 11.2.1 Pfizer Company Detail 11.2.2 Pfizer Business Overview 11.2.3 Pfizer Squamous Cell Carcinoma of the Head and Neck Treatment Introduction 11.2.4 Pfizer Revenue in Squamous Cell Carcinoma of the Head and Neck Treatment Business (2017-2022) 11.2.5 Pfizer Recent Development 11.3 Eli Lilly 11.3.1 Eli Lilly Company Detail 11.3.2 Eli Lilly Business Overview 11.3.3 Eli Lilly Squamous Cell Carcinoma of the Head and Neck Treatment Introduction 11.3.4 Eli Lilly Revenue in Squamous Cell Carcinoma of the Head and Neck Treatment Business (2017-2022) 11.3.5 Eli Lilly Recent Development 11.4 Bristol-Myers Squibb 11.4.1 Bristol-Myers Squibb Company Detail 11.4.2 Bristol-Myers Squibb Business Overview 11.4.3 Bristol-Myers Squibb Squamous Cell Carcinoma of the Head and Neck Treatment Introduction 11.4.4 Bristol-Myers Squibb Revenue in Squamous Cell Carcinoma of the Head and Neck Treatment Business (2017-2022) 11.4.5 Bristol-Myers Squibb Recent Development 11.5 Merck 11.5.1 Merck Company Detail 11.5.2 Merck Business Overview 11.5.3 Merck Squamous Cell Carcinoma of the Head and Neck Treatment Introduction 11.5.4 Merck Revenue in Squamous Cell Carcinoma of the Head and Neck Treatment Business (2017-2022) 11.5.5 Merck Recent Development 11.6 Bayer 11.6.1 Bayer Company Detail 11.6.2 Bayer Business Overview 11.6.3 Bayer Squamous Cell Carcinoma of the Head and Neck Treatment Introduction 11.6.4 Bayer Revenue in Squamous Cell Carcinoma of the Head and Neck Treatment Business (2017-2022) 11.6.5 Bayer Recent Development 11.7 Fresenius 11.7.1 Fresenius Company Detail 11.7.2 Fresenius Business Overview 11.7.3 Fresenius Squamous Cell Carcinoma of the Head and Neck Treatment Introduction 11.7.4 Fresenius Revenue in Squamous Cell Carcinoma of the Head and Neck Treatment Business (2017-2022) 11.7.5 Fresenius Recent Development 11.8 Teva Pharmaceutical 11.8.1 Teva Pharmaceutical Company Detail 11.8.2 Teva Pharmaceutical Business Overview 11.8.3 Teva Pharmaceutical Squamous Cell Carcinoma of the Head and Neck Treatment Introduction 11.8.4 Teva Pharmaceutical Revenue in Squamous Cell Carcinoma of the Head and Neck Treatment Business (2017-2022) 11.8.5 Teva Pharmaceutical Recent Development 11.9 AB SCIENCE 11.9.1 AB SCIENCE Company Detail 11.9.2 AB SCIENCE Business Overview 11.9.3 AB SCIENCE Squamous Cell Carcinoma of the Head and Neck Treatment Introduction 11.9.4 AB SCIENCE Revenue in Squamous Cell Carcinoma of the Head and Neck Treatment Business (2017-2022) 11.9.5 AB SCIENCE Recent Development 11.10 AbbVie 11.10.1 AbbVie Company Detail 11.10.2 AbbVie Business Overview 11.10.3 AbbVie Squamous Cell Carcinoma of the Head and Neck Treatment Introduction 11.10.4 AbbVie Revenue in Squamous Cell Carcinoma of the Head and Neck Treatment Business (2017-2022) 11.10.5 AbbVie Recent Development 11.11 Acceleron Pharma 11.11.1 Acceleron Pharma Company Detail 11.11.2 Acceleron Pharma Business Overview 11.11.3 Acceleron Pharma Squamous Cell Carcinoma of the Head and Neck Treatment Introduction 11.11.4 Acceleron Pharma Revenue in Squamous Cell Carcinoma of the Head and Neck Treatment Business (2017-2022) 11.11.5 Acceleron Pharma Recent Development 11.12 Astellas Pharma 11.12.1 Astellas Pharma Company Detail 11.12.2 Astellas Pharma Business Overview 11.12.3 Astellas Pharma Squamous Cell Carcinoma of the Head and Neck Treatment Introduction 11.12.4 Astellas Pharma Revenue in Squamous Cell Carcinoma of the Head and Neck Treatment Business (2017-2022) 11.12.5 Astellas Pharma Recent Development 11.13 AstraZeneca 11.13.1 AstraZeneca Company Detail 11.13.2 AstraZeneca Business Overview 11.13.3 AstraZeneca Squamous Cell Carcinoma of the Head and Neck Treatment Introduction 11.13.4 AstraZeneca Revenue in Squamous Cell Carcinoma of the Head and Neck Treatment Business (2017-2022) 11.13.5 AstraZeneca Recent Development 11.14 Sumitomo Dainippon Pharma 11.14.1 Sumitomo Dainippon Pharma Company Detail 11.14.2 Sumitomo Dainippon Pharma Business Overview 11.14.3 Sumitomo Dainippon Pharma Squamous Cell Carcinoma of the Head and Neck Treatment Introduction 11.14.4 Sumitomo Dainippon Pharma Revenue in Squamous Cell Carcinoma of the Head and Neck Treatment Business (2017-2022) 11.14.5 Sumitomo Dainippon Pharma Recent Development 11.15 GENERAL ELECTRIC COMPANY 11.15.1 GENERAL ELECTRIC COMPANY Company Detail 11.15.2 GENERAL ELECTRIC COMPANY Business Overview 11.15.3 GENERAL ELECTRIC COMPANY Squamous Cell Carcinoma of the Head and Neck Treatment Introduction 11.15.4 GENERAL ELECTRIC COMPANY Revenue in Squamous Cell Carcinoma of the Head and Neck Treatment Business (2017-2022) 11.15.5 GENERAL ELECTRIC COMPANY Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Squamous Cell Carcinoma of the Head and Neck Treatment Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028 Table 2. Key Players of Salivary Gland Table 3. Key Players of Oral & Oropharyngeal Table 4. Key Players of Nasal Cavity & Paranasal Sinus Table 5. Key Players of Nasopharyngeal Table 6. Key Players of Laryngeal & Hypo Pharyngeal Table 7. Global Squamous Cell Carcinoma of the Head and Neck Treatment Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028 Table 8. Global Squamous Cell Carcinoma of the Head and Neck Treatment Market Size by Region (US$ Million): 2017 VS 2021 VS 2028 Table 9. Global Squamous Cell Carcinoma of the Head and Neck Treatment Market Size by Region (2017-2022) & (US$ Million) Table 10. Global Squamous Cell Carcinoma of the Head and Neck Treatment Market Share by Region (2017-2022) Table 11. Global Squamous Cell Carcinoma of the Head and Neck Treatment Forecasted Market Size by Region (2023-2028) & (US$ Million) Table 12. Global Squamous Cell Carcinoma of the Head and Neck Treatment Market Share by Region (2023-2028) Table 13. Squamous Cell Carcinoma of the Head and Neck Treatment Market Trends Table 14. Squamous Cell Carcinoma of the Head and Neck Treatment Market Drivers Table 15. Squamous Cell Carcinoma of the Head and Neck Treatment Market Challenges Table 16. Squamous Cell Carcinoma of the Head and Neck Treatment Market Restraints Table 17. Global Squamous Cell Carcinoma of the Head and Neck Treatment Revenue by Players (2017-2022) & (US$ Million) Table 18. Global Squamous Cell Carcinoma of the Head and Neck Treatment Market Share by Players (2017-2022) Table 19. Global Top Squamous Cell Carcinoma of the Head and Neck Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Squamous Cell Carcinoma of the Head and Neck Treatment as of 2021) Table 20. Ranking of Global Top Squamous Cell Carcinoma of the Head and Neck Treatment Companies by Revenue (US$ Million) in 2021 Table 21. Global 5 Largest Players Market Share by Squamous Cell Carcinoma of the Head and Neck Treatment Revenue (CR5 and HHI) & (2017-2022) Table 22. Key Players Headquarters and Area Served Table 23. Key Players Squamous Cell Carcinoma of the Head and Neck Treatment Product Solution and Service Table 24. Date of Enter into Squamous Cell Carcinoma of the Head and Neck Treatment Market Table 25. Mergers & Acquisitions, Expansion Plans Table 26. Global Squamous Cell Carcinoma of the Head and Neck Treatment Market Size by Type (2017-2022) & (US$ Million) Table 27. Global Squamous Cell Carcinoma of the Head and Neck Treatment Revenue Market Share by Type (2017-2022) Table 28. Global Squamous Cell Carcinoma of the Head and Neck Treatment Forecasted Market Size by Type (2023-2028) & (US$ Million) Table 29. Global Squamous Cell Carcinoma of the Head and Neck Treatment Revenue Market Share by Type (2023-2028) Table 30. Global Squamous Cell Carcinoma of the Head and Neck Treatment Market Size by Application (2017-2022) & (US$ Million) Table 31. Global Squamous Cell Carcinoma of the Head and Neck Treatment Revenue Market Share by Application (2017-2022) Table 32. Global Squamous Cell Carcinoma of the Head and Neck Treatment Forecasted Market Size by Application (2023-2028) & (US$ Million) Table 33. Global Squamous Cell Carcinoma of the Head and Neck Treatment Revenue Market Share by Application (2023-2028) Table 34. North America Squamous Cell Carcinoma of the Head and Neck Treatment Market Size by Country (2017-2022) & (US$ Million) Table 35. North America Squamous Cell Carcinoma of the Head and Neck Treatment Market Size by Country (2023-2028) & (US$ Million) Table 36. Europe Squamous Cell Carcinoma of the Head and Neck Treatment Market Size by Country (2017-2022) & (US$ Million) Table 37. Europe Squamous Cell Carcinoma of the Head and Neck Treatment Market Size by Country (2023-2028) & (US$ Million) Table 38. Asia-Pacific Squamous Cell Carcinoma of the Head and Neck Treatment Market Size by Region (2017-2022) & (US$ Million) Table 39. Asia-Pacific Squamous Cell Carcinoma of the Head and Neck Treatment Market Size by Region (2023-2028) & (US$ Million) Table 40. Latin America Squamous Cell Carcinoma of the Head and Neck Treatment Market Size by Country (2017-2022) & (US$ Million) Table 41. Latin America Squamous Cell Carcinoma of the Head and Neck Treatment Market Size by Country (2023-2028) & (US$ Million) Table 42. Middle East & Africa Squamous Cell Carcinoma of the Head and Neck Treatment Market Size by Country (2017-2022) & (US$ Million) Table 43. Middle East & Africa Squamous Cell Carcinoma of the Head and Neck Treatment Market Size by Country (2023-2028) & (US$ Million) Table 44. Sanofi Company Detail Table 45. Sanofi Business Overview Table 46. Sanofi Squamous Cell Carcinoma of the Head and Neck Treatment Product Table 47. Sanofi Revenue in Squamous Cell Carcinoma of the Head and Neck Treatment Business (2017-2022) & (US$ Million) Table 48. Sanofi Recent Development Table 49. Pfizer Company Detail Table 50. Pfizer Business Overview Table 51. Pfizer Squamous Cell Carcinoma of the Head and Neck Treatment Product Table 52. Pfizer Revenue in Squamous Cell Carcinoma of the Head and Neck Treatment Business (2017-2022) & (US$ Million) Table 53. Pfizer Recent Development Table 54. Eli Lilly Company Detail Table 55. Eli Lilly Business Overview Table 56. Eli Lilly Squamous Cell Carcinoma of the Head and Neck Treatment Product Table 57. Eli Lilly Revenue in Squamous Cell Carcinoma of the Head and Neck Treatment Business (2017-2022) & (US$ Million) Table 58. Eli Lilly Recent Development Table 59. Bristol-Myers Squibb Company Detail Table 60. Bristol-Myers Squibb Business Overview Table 61. Bristol-Myers Squibb Squamous Cell Carcinoma of the Head and Neck Treatment Product Table 62. Bristol-Myers Squibb Revenue in Squamous Cell Carcinoma of the Head and Neck Treatment Business (2017-2022) & (US$ Million) Table 63. Bristol-Myers Squibb Recent Development Table 64. Merck Company Detail Table 65. Merck Business Overview Table 66. Merck Squamous Cell Carcinoma of the Head and Neck Treatment Product Table 67. Merck Revenue in Squamous Cell Carcinoma of the Head and Neck Treatment Business (2017-2022) & (US$ Million) Table 68. Merck Recent Development Table 69. Bayer Company Detail Table 70. Bayer Business Overview Table 71. Bayer Squamous Cell Carcinoma of the Head and Neck Treatment Product Table 72. Bayer Revenue in Squamous Cell Carcinoma of the Head and Neck Treatment Business (2017-2022) & (US$ Million) Table 73. Bayer Recent Development Table 74. Fresenius Company Detail Table 75. Fresenius Business Overview Table 76. Fresenius Squamous Cell Carcinoma of the Head and Neck Treatment Product Table 77. Fresenius Revenue in Squamous Cell Carcinoma of the Head and Neck Treatment Business (2017-2022) & (US$ Million) Table 78. Fresenius Recent Development Table 79. Teva Pharmaceutical Company Detail Table 80. Teva Pharmaceutical Business Overview Table 81. Teva Pharmaceutical Squamous Cell Carcinoma of the Head and Neck Treatment Product Table 82. Teva Pharmaceutical Revenue in Squamous Cell Carcinoma of the Head and Neck Treatment Business (2017-2022) & (US$ Million) Table 83. Teva Pharmaceutical Recent Development Table 84. AB SCIENCE Company Detail Table 85. AB SCIENCE Business Overview Table 86. AB SCIENCE Squamous Cell Carcinoma of the Head and Neck Treatment Product Table 87. AB SCIENCE Revenue in Squamous Cell Carcinoma of the Head and Neck Treatment Business (2017-2022) & (US$ Million) Table 88. AB SCIENCE Recent Development Table 89. AbbVie Company Detail Table 90. AbbVie Business Overview Table 91. AbbVie Squamous Cell Carcinoma of the Head and Neck Treatment Product Table 92. AbbVie Revenue in Squamous Cell Carcinoma of the Head and Neck Treatment Business (2017-2022) & (US$ Million) Table 93. AbbVie Recent Development Table 94. Acceleron Pharma Company Detail Table 95. Acceleron Pharma Business Overview Table 96. Acceleron Pharma Squamous Cell Carcinoma of the Head and Neck TreatmentProduct Table 97. Acceleron Pharma Revenue in Squamous Cell Carcinoma of the Head and Neck Treatment Business (2017-2022) & (US$ Million) Table 98. Acceleron Pharma Recent Development Table 99. Astellas Pharma Company Detail Table 100. Astellas Pharma Business Overview Table 101. Astellas Pharma Squamous Cell Carcinoma of the Head and Neck TreatmentProduct Table 102. Astellas Pharma Revenue in Squamous Cell Carcinoma of the Head and Neck Treatment Business (2017-2022) & (US$ Million) Table 103. Astellas Pharma Recent Development Table 104. AstraZeneca Company Detail Table 105. AstraZeneca Business Overview Table 106. AstraZeneca Squamous Cell Carcinoma of the Head and Neck TreatmentProduct Table 107. AstraZeneca Revenue in Squamous Cell Carcinoma of the Head and Neck Treatment Business (2017-2022) & (US$ Million) Table 108. AstraZeneca Recent Development Table 109. Sumitomo Dainippon Pharma Company Detail Table 110. Sumitomo Dainippon Pharma Business Overview Table 111. Sumitomo Dainippon Pharma Squamous Cell Carcinoma of the Head and Neck TreatmentProduct Table 112. Sumitomo Dainippon Pharma Revenue in Squamous Cell Carcinoma of the Head and Neck Treatment Business (2017-2022) & (US$ Million) Table 113. Sumitomo Dainippon Pharma Recent Development Table 114. GENERAL ELECTRIC COMPANY Company Detail Table 115. GENERAL ELECTRIC COMPANY Business Overview Table 116. GENERAL ELECTRIC COMPANY Squamous Cell Carcinoma of the Head and Neck TreatmentProduct Table 117. GENERAL ELECTRIC COMPANY Revenue in Squamous Cell Carcinoma of the Head and Neck Treatment Business (2017-2022) & (US$ Million) Table 118. GENERAL ELECTRIC COMPANY Recent Development Table 119. Research Programs/Design for This Report Table 120. Key Data Information from Secondary Sources Table 121. Key Data Information from Primary Sources List of Figures Figure 1. Global Squamous Cell Carcinoma of the Head and Neck Treatment Market Share by Type: 2021 VS 2028 Figure 2. Salivary Gland Features Figure 3. Oral & Oropharyngeal Features Figure 4. Nasal Cavity & Paranasal Sinus Features Figure 5. Nasopharyngeal Features Figure 6. Laryngeal & Hypo Pharyngeal Features Figure 7. Global Squamous Cell Carcinoma of the Head and Neck Treatment Market Share by Application in 2021 & 2028 Figure 8. Hospitals Case Studies Figure 9. Specialty Clinics Case Studies Figure 10. Ambulatory Surgical Centers Case Studies Figure 11. Squamous Cell Carcinoma of the Head and Neck Treatment Report Years Considered Figure 12. Global Squamous Cell Carcinoma of the Head and Neck Treatment Market Size (US$ Million), Year-over-Year: 2017-2028 Figure 13. Global Squamous Cell Carcinoma of the Head and Neck Treatment Market Size, (US$ Million), 2017 VS 2021 VS 2028 Figure 14. Global Squamous Cell Carcinoma of the Head and Neck Treatment Market Share by Region: 2021 VS 2028 Figure 15. Global Squamous Cell Carcinoma of the Head and Neck Treatment Market Share by Players in 2021 Figure 16. Global Top Squamous Cell Carcinoma of the Head and Neck Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Squamous Cell Carcinoma of the Head and Neck Treatment as of 2021) Figure 17. The Top 10 and 5 Players Market Share by Squamous Cell Carcinoma of the Head and Neck Treatment Revenue in 2021 Figure 18. North America Squamous Cell Carcinoma of the Head and Neck Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 19. North America Squamous Cell Carcinoma of the Head and Neck Treatment Market Share by Country (2017-2028) Figure 20. United States Squamous Cell Carcinoma of the Head and Neck Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 21. Canada Squamous Cell Carcinoma of the Head and Neck Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 22. Europe Squamous Cell Carcinoma of the Head and Neck Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 23. Europe Squamous Cell Carcinoma of the Head and Neck Treatment Market Share by Country (2017-2028) Figure 24. Germany Squamous Cell Carcinoma of the Head and Neck Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 25. France Squamous Cell Carcinoma of the Head and Neck Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 26. U.K. Squamous Cell Carcinoma of the Head and Neck Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 27. Italy Squamous Cell Carcinoma of the Head and Neck Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 28. Russia Squamous Cell Carcinoma of the Head and Neck Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 29. Nordic Countries Squamous Cell Carcinoma of the Head and Neck Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 30. Asia-Pacific Squamous Cell Carcinoma of the Head and Neck Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 31. Asia-Pacific Squamous Cell Carcinoma of the Head and Neck Treatment Market Share by Region (2017-2028) Figure 32. China Squamous Cell Carcinoma of the Head and Neck Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 33. Japan Squamous Cell Carcinoma of the Head and Neck Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 34. South Korea Squamous Cell Carcinoma of the Head and Neck Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 35. Southeast Asia Squamous Cell Carcinoma of the Head and Neck Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 36. India Squamous Cell Carcinoma of the Head and Neck Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 37. Australia Squamous Cell Carcinoma of the Head and Neck Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 38. Latin America Squamous Cell Carcinoma of the Head and Neck Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 39. Latin America Squamous Cell Carcinoma of the Head and Neck Treatment Market Share by Country (2017-2028) Figure 40. Mexico Squamous Cell Carcinoma of the Head and Neck Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 41. Brazil Squamous Cell Carcinoma of the Head and Neck Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 42. Middle East & Africa Squamous Cell Carcinoma of the Head and Neck Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 43. Middle East & Africa Squamous Cell Carcinoma of the Head and Neck Treatment Market Share by Country (2017-2028) Figure 44. Turkey Squamous Cell Carcinoma of the Head and Neck Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 45. Saudi Arabia Squamous Cell Carcinoma of the Head and Neck Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 46. Sanofi Revenue Growth Rate in Squamous Cell Carcinoma of the Head and Neck Treatment Business (2017-2022) Figure 47. Pfizer Revenue Growth Rate in Squamous Cell Carcinoma of the Head and Neck Treatment Business (2017-2022) Figure 48. Eli Lilly Revenue Growth Rate in Squamous Cell Carcinoma of the Head and Neck Treatment Business (2017-2022) Figure 49. Bristol-Myers Squibb Revenue Growth Rate in Squamous Cell Carcinoma of the Head and Neck Treatment Business (2017-2022) Figure 50. Merck Revenue Growth Rate in Squamous Cell Carcinoma of the Head and Neck Treatment Business (2017-2022) Figure 51. Bayer Revenue Growth Rate in Squamous Cell Carcinoma of the Head and Neck Treatment Business (2017-2022) Figure 52. Fresenius Revenue Growth Rate in Squamous Cell Carcinoma of the Head and Neck Treatment Business (2017-2022) Figure 53. Teva Pharmaceutical Revenue Growth Rate in Squamous Cell Carcinoma of the Head and Neck Treatment Business (2017-2022) Figure 54. AB SCIENCE Revenue Growth Rate in Squamous Cell Carcinoma of the Head and Neck Treatment Business (2017-2022) Figure 55. AbbVie Revenue Growth Rate in Squamous Cell Carcinoma of the Head and Neck Treatment Business (2017-2022) Figure 56. Acceleron Pharma Revenue Growth Rate in Squamous Cell Carcinoma of the Head and Neck Treatment Business (2017-2022) Figure 57. Astellas Pharma Revenue Growth Rate in Squamous Cell Carcinoma of the Head and Neck Treatment Business (2017-2022) Figure 58. AstraZeneca Revenue Growth Rate in Squamous Cell Carcinoma of the Head and Neck Treatment Business (2017-2022) Figure 59. Sumitomo Dainippon Pharma Revenue Growth Rate in Squamous Cell Carcinoma of the Head and Neck Treatment Business (2017-2022) Figure 60. GENERAL ELECTRIC COMPANY Revenue Growth Rate in Squamous Cell Carcinoma of the Head and Neck Treatment Business (2017-2022) Figure 61. Bottom-up and Top-down Approaches for This Report Figure 62. Data Triangulation Figure 63. Key Executives Interviewed

Sanofi Pfizer Eli Lilly Bristol-Myers Squibb Merck Bayer Fresenius Teva Pharmaceutical AB SCIENCE AbbVie Acceleron Pharma Astellas Pharma AstraZeneca Sumitomo Dainippon Pharma GENERAL ELECTRIC COMPANY